指南与共识腹部介入CT

胰腺肿瘤不可逆电穿孔共识指南:采用改良德尔菲技术实现方案标准化

Consensus Guidelines of Irreversible Electroporation for Pancreatic Tumors: Protocol Standardization Using the Modified Delphi Technique.
指南 / 共识 · Semin Intervent Radiol · 2024-07-10

该共识通过改良德尔菲技术组织11名专家进行三轮匿名问卷,共识阈值定为≥80%同意率,最终93%的条目达成共识。共识推荐胰腺不可逆电穿孔用于Ⅲ期胰腺癌及既往局部治疗后无法手术的复发病例,并给出绝对禁忌证、电极参数、脉冲方案及术后1个月起每3个月复查增强CT的随访安排。

要点

  • 胰腺不可逆电穿孔适用于Ⅲ期胰腺癌及既往局部治疗后无法手术的复发灶。
  • 绝对禁忌证包括室性心律失常、植入式刺激装置、NYHA 4级充血性心力衰竭和严重腹水。
  • 电极间距10至20 mm、暴露长度15 mm,10次测试脉冲后连续给予90次1500 V/cm治疗脉冲,脉宽90 µs。

核心结论

  • 该改良德尔菲共识就胰腺恶性肿瘤IRE的患者选择、操作方案和随访给出专家推荐,未来研究需明确最大肿瘤直径、疗效评价标准及术前FOLFIRINOX最佳周期数。

研究设计与样本

  • 改良德尔菲共识研究,按既往IRE发表情况预设标准招募11名专家,进行三轮匿名问卷,共识定义为同意率≥80%。

诊断标准与关键数值

  • 三轮问卷应答率分别为100%、64%、64%,93%的条目达成共识;电极间距10至20 mm、暴露长度15 mm;10次测试脉冲后连续给予90次1500 V/cm治疗脉冲、脉宽90 µs;首次术后增强CT于IRE后1个月进行,之后每3个月复查。

临床应用与阅片要点

  • 推荐将胰腺IRE用于Ⅲ期胰腺癌及既往局部治疗后无法手术的复发灶,并照此方案选择患者、设置电极与脉冲参数、安排术后增强CT随访。

局限性

  • 第1至3轮问卷应答率分别为100%、64%、64%。
  • 未来研究应明确最大肿瘤直径、疗效评价标准及术前FOLFIRINOX最佳周期数。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Since no uniform treatment protocol for pancreatic irreversible electroporation (IRE) exists, the heterogeneity throughout literature complicates the comparison of results. To reach agreement among experts, a consensus study was performed. Eleven experts, recruited according to predefined criteria regarding previous IRE publications, participated anonymously in three rounds of questionnaires according to a modified Delphi technique. Consensus was defined as having reached ≥80% agreement. Response rates were 100, 64, and 64% in rounds 1 to 3, respectively; consensus was reached in 93%. Pancreatic IRE should be considered for stage III pancreatic cancer and inoperable recurrent disease after previous local treatment. Absolute contraindications are ventricular arrhythmias, implantable stimulation devices, congestive heart failure NYHA class 4, and severe ascites. The inter-electrode distance should be 10 to 20 mm and the exposure length should be 15 mm. After 10 test pulses, 90 treatment pulses of 1,500 V/cm should be delivered continuously, with a 90-µs pulse length. The first postprocedural contrast-enhanced computed tomography should take place 1 month post-IRE, and then every 3 months. This article provides expert recommendations regarding patient selection, procedure, and follow-up for IRE treatment in pancreatic malignancies through a modified Delphi consensus study. Future studies should define the maximum tumor diameter, response evaluation criteria, and the optimal number of preoperative FOLFIRINOX cycles.

来源:Semin Intervent Radiol,查看原文。版权归原作者所有。

引用

  1. Vos DJW, Ruarus AH, Timmer FEF, et al. Consensus Guidelines of Irreversible Electroporation for Pancreatic Tumors: Protocol Standardization Using the Modified Delphi Technique. Semin Intervent Radiol. 2024. PMID: 38993594. doi:10.1055/s-0044-1787164

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。